Samuel D. Colella, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 2,000 shares at $10.74 ($21K) on 2019-08-08, disclosed to the SEC on 2019-08-09.
Open-market purchase of $21k FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| FLDM | BUY | 2019-08-12 | $7K | — | Filing → |
| FLDM | BUY | 2019-08-08 | $63K | — | Filing → |
| FLDM | BUY | 2017-08-08 | $199K | — | Filing → |